Biomarker ID | 1215 |
PMID | 24080222 |
Year | 2013 |
Biomarker | PCA3 + Multiparametric MRI |
Biomarker Basis | Expression Based |
Biomolecule | Others |
Source | Urine + Technique |
Subjects | Humans |
Regulation | PCA3 Upregulated in PCa |
Odds Ratio/Hazard Ratio/Relative Risk | NA |
Effect on Pathways | NA |
Experiment | Prostate Cancer Vs Normal Prostate |
Type of Biomarker | Diagnostic |
Cohort | 71 consecutive patients with clinically suspected PCa were included in the study. 68 had PCa and 95 did not. |
Senstivity | NA |
Specificity | NA |
AUC | 0.808 (95% CI: 0.742-0.847) |
Accuracy | NA |
Level Of Significance | NA |
Method Used | NA |
Clinical | No |
Remarks | Predictor is Base model + PCA3+ MSRI. Base Model = age, PSA level, and DRE findings |
Clinical Trial Number | NA |
Degree Of Validity | Not validated on independent patient dataset |
Technical Name | NA |